Potential peripheral biological predictors of suicidal behavior in major depressive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 4, 2011, Pages 842-847

  Lee, Bun Hee ^a   Kim, Yong Ku ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

BDNF; Cholesterol; Hypothalamic pituitary adrenal; Neurobiology; Serotonin; Suicide

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANTILIPEMIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLESTEROL; CORTICOTROPIN RELEASING FACTOR; PROLACTIN; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER;

CEREBROSPINAL FLUID; CHILD ABUSE; CHOLESTEROL BLOOD LEVEL; DEXAMETHASONE SUPPRESSION TEST; HEREDITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; NERVE CELL PLASTICITY; NEUROBIOLOGY; PREFRONTAL CORTEX; RISK FACTOR; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION; SHORT SURVEY; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; WISCONSIN CARD SORTING TEST;

BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHOLESTEROL; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROBIOLOGY; PREDICTIVE VALUE OF TESTS; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; SUICIDE;

EID: 79956020090     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.08.001     Document Type: Short Survey

References (90)

1. Agargun M.Y., Cartwright R. REM sleep, dream variables and suicidality in depressed patients. Psychiatry Res 2003, 119:33-39.
2. Alvarez J.-C., Cremniter D., Gluck N., Quintin P., Leboyer M., Berlin I., Therond P., Spreux-Varoquaux O. Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Res 2000, 95:103-108.
3. Arango V., Ernsberger P., Marzuk P.M., Chen J.S., Tierney H., Stanley M., Reis D.J., Mann J.J. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 1990, 47:1038-1047.
4. Arato M., Banki C.M., Bissette G., Nemeroff C.B. Elevated CSF CRF in suicide victims. Biol Psychiatry 1989, 25:355-359.
5. Arora R.C., Meltzer H.Y. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 1989, 146:730-736.
6. Arranz B., Eriksson A., Mellerup E., Plenge P., Marcusson J. Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol Psychiatry 1994, 35:457-463.
7. Asberg M., Thoren P., Traskman L., Bertilsson L., Ringberger V. "Serotonin depression"-a biochemical subgroup within the affective disorders?. Science 1976, 191:478-480.
8. Asberg M., Träskman L., Thorén P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?. Arch Gen Psychiatry 1976, 33:1193-1197.
9. Bach-Mizrachi H., Underwood M.D., Kassir S.A., Bakalian M.J., Sibille E., Tamir H., Mann J.J., Arango V. Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacology 2006, 31:814-824.
10. Black D.W., Monahan P.O., Winokur G. The relationship between DST results and suicidal behavior. Ann Clin Psychiatry 2002, 14:83-88.
11. Boldrini M., Underwood M.D., Mann J.J., Arango V. More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res 2005, 1041:19-28.
12. Bonkale W.L., Turecki G., Austin M.C. Increased tryptophan hydroxylase immunoreactivity in the dorsal raphe nucleus of alcohol-dependent, depressed suicide subjects is restricted to the dorsal subnucleus. Synapse 2006, 60:81-85.
13. Carlson G.A., Rich C.L., Grayson P., Fowler R.C. Secular trends in psychiatric diagnoses of suicide victims. J Affect Disord 1991, 21:127-132.
14. Chen T.J., Yu Y.W., Chen M.C., Wang S.Y., Tsai S.J., Lee T.W. Serotonin dysfunction and suicide attempts in major depressives: an auditory event-related potential study. Neuropsychobiology 2005, 52:28-36.
15. Cohen J. Statistical approaches to suicidal risk factor analysis. Ann NY Acad Sci 1986, 487:34-41.
16. Corrêa H., Duval F., Mokrani M., Bailey P., Trémeau F., Staner L., Diep T.S., Hodé Y., Crocq M.A., Macher J.P. Prolactin response to d-fenfluramine and suicidal behavior in depressed patients. Psychiatry Res 2000, 93:189-199.
17. Coryell W. DST abnormality as a predictor of course in major depression. J Affect Disord 1990, 19:163-169.
18. Coryell W., Schlesser M. The dexamethasone suppression test and suicide prediction. Am J Psychiatry 2001, 158:748-753.
19. Coryell W., Schlesser M. Combined biological tests for suicide prediction. Psychiatry Res 2007, 150:187-191.
20. Coryell W., Young E., Carroll B. Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder. Psychiatry Res 2006, 142:99-104.
21. Currier D., Mann J.J. Stress, genes and the biology of suicidal behavior. Psychiatr Clin North Am 2008, 31:247-269.
22. Dawood T., Anderson J., Barton D., Lambert E., Esler M., Hotchkin E., Haikerwal D., Kaye D., Lambert G. Reduced overflow of BDNF from the brain is linked with suicide risk in depressive illness. Mol Psychiatry 2007, 12:981-983.
23. Deveci A., Aydemir O., Taskin O., Taneli F., Esen-Danaci A. Serum BDNF levels in suicide attempters related to psychosocial stressors: a comparative study with depression. Neuropsychobiology 2007, 56:93-97.
24. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997, 54:597-606.
25. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003, 60:804-815.
26. Dwivedi Y., Rizavi H.S., Zhang H., Mondal A.C., Roberts R.C., Conley R.R., Pandey G.N. Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide. Biol Psychiatry 2009, 65:319-328.
27. Ellison L.F., Morrison H.I. Low serum cholesterol concentration and risk of suicide. Epidemiology 2001, 12:168-172.
28. Ernst C., Deleva V., Deng X., Sequeira A., Pomarenski A., Klempan T., Ernst N., Quirion R., Gratton A., Szyf M., Turecki G. Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch Gen Psychiatry 2009, 66:22-32.
29. Ernst C., Mechawar N., Turecki G. Suicide neurobiology. Prog Neurobiol 2009, 89:315-333.
30. Frick M.H., Elo O., Haapa K., Heinonen O.P., Heinsalmi P., Helo P., Huttunen J.K., Kaitaniemi P., Koskinen P., Manninen V., et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987, 317:1237-1245.
31. Graae F., Tenke C., Bruder G., Rotheram M.J., Piacentini J., Castro-Blanco D., Leite P., Towey J. Abnormality of EEG alpha asymmetry in female adolescent suicide attempters. Biol Psychiatry 1996, 40:706-713.
32. Hegerl U., Gallinat J., Juckel G. Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?. J Affect Disord 2001, 62:93-100.
33. Heron D.S., Shinitzky M., Hershkowitz M., Samuel D. Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci USA 1980, 77:7463-7467.
34. Hou C., Jia F., Liu Y., Li L. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder. Brain Res 2006, 1095:154-158.
35. Iribarren C., Reed D.M., Wergowske G., Burchfiel C.M., Dwyer J.H. Serum cholesterol level andmortality due to suicide and trauma in the Honolulu Heart Program. Arch Intern Med 1995, 155:695-700.
36. Jokinen J., Nordström P. HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients. Psychoneuroendocrinology 2008, 33:1387-1393.
37. Jokinen J., Carlborg A., Mårtensson B., Forslund K., Nordström A.L., Nordström P. DST non-suppression predicts suicide after attempted suicide. Psychiatry Res 2007, 150:297-303.
38. Jokinen J., Mårtensson B., Nordström A.L., Nordström P. CSF 5-HIAA and DST non-suppression-independent biomarkers in suicide attempters?. J Affect Disord 2008, 105:241-245.
39. Jokinen J., Nordström A.L., Nordström P. ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide. J Affect Disord 2008, 106:145-152.
40. Jokinen J., Nordström A.L., Nordström P. CSF 5-HIAA and DST non-suppression-orthogonal biologic risk factors for suicide in male mood disorder inpatients. Psychiatry Res 2009, 165:96-102.
41. Kaplan J.R., Muldoon M.F., Manuck S.B., Mann J.J. Assessing the observed relationship between low cholesterol and violencerelated mortality: implications for suicide risk. Ann NY Acad Sci 1997, 863:57-80.
42. Karege F., Vaudan G., Schwald M., Perroud N., La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 2005, 136:29-37.
43. Keilp J.G., Sackeim H.A., Brodsky B.S., Oquendo M.A., Malone K.M., Mann J.J. Neuropsychological dysfunction in depressed suicide attempters. Am J Psychiatry 2001, 158:735-741.
44. Kim Y.K., Myint A.M. Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. J Affect Disord 2004, 81:161-166.
45. Kim Y.K., Lee H.J., Kim J.Y., Yoon D.K., Choi S.H., Lee M.S. Low serum cholesterol is correlated to suicidality in a Korean sample. Acta Psychiatr Scand 2002, 105:141-148.
46. Kim Y.K., Lee H.P., Won S.D., Park E.Y., Lee H.Y., Lee B.H., Lee S.W., Yoon D., Han C., Kim D.J., Choi S.H. Low plasma BDNF is associated with suicidal behavior in depression. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:578-579.
47. Kunugi H., Takei N., Aoki H., Nanko S. Low serum cholesterol in suicide attempters. Biol Psychiatry 1997, 41:196-200.
48. Kunugi H., Urushibara T., Nanko S. Combined DEX/CRH test among Japanese patients with major depression. J Psychiatr Res 2004, 38:123-128.
49. Lee H.J., Kim Y.K. Serum lipid levels and suicide attempts. Acta Psychiatr Scand 2003, 108:215-221.
50. Lee B.H., Kim Y.K. BDNF mRNA expression of peripheral blood mononuclear cells was decreased in depressive patients who had or had not recently attempted suicide. J Affect Disord 2010, [In print].
51. Lee B.H., Kim H., Park S.H., Kim Y.K. Decreased plasma BDNF level in depressive patients. J Affect Disord 2007, 101:239-244.
52. Lester D. The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry 1995, 28:77-79.
53. Leyton M., Paquette V., Gravel P., Rosa-Neto P., Weston F., Diksic M., Benkelfat C. Alpha-[11C]methyl-l-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters. Eur Neuropsychopharmacol 2006, 16:220-223.
54. Malone K.M., Corbitt E.M., Li S., Mann J.J. Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 1996, 168:324-329.
55. Malone K.M., Ellis S.P., Currier D., John Mann J. Platelet 5-HT2A receptor subresponsivity and lethality of attempted suicide in depressed in-patients. Int J Neuropsychopharmacol 2007, 10:335-343.
56. Mann J.J. A current perspective of suicide and attempted suicide. Ann Intern Med 2002, 136:302-311.
57. Mann J.J., McBride P.A., Malone K.M., DeMeo M., Keilp J. Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology 1995, 13:53-64.
58. Mann J.J., Waternaux C., Haas G.L., Malone K.M. Towards a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 1999, 156:181-189.
59. Mann J.J., Huang Y.Y., Underwood M.D., Kassir S.A., Oppenheim S., Kelly T.M., Dwork A.J. V. A. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 2000, 57:729-738.
60. Mann J.J., Currier D., Stanley B., Oquendo M.A., Amsel L.V., Ellis S.P. Can biological tests assist prediction of suicide in mood disorders?. Int J Neuropsychopharmacol 2006, 9:465-474.
61. Mauch D.H., Nagler K., Schumacher S., Goritz C., Muller E.C., Otto A., Pfrieger F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001, 294:1354-1357.
62. Muldoon M.F., Manuck S.B., Matthews K.A. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990, 301:309-314.
63. Muldoon M.F., Manuck S.B., Mendelsohn A.B., Kaplan J.R., Belle S.H. Cholesterol reduction and non-illness mortality: meta-analysis of randomised clinical trials. BMJ 2001, 322:11-15.
64. New A.S., Trestman R.L., Mitropoulou V., Benishay D.S., Coccaro E., Silverman J., Siever L.J. Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Res 1997, 69:17-26.
65. Nordström P., Samuelsson M., Asberg M., Träskman-Bendz L., Aberg-Wistedt A., Nordin C., Bertilsson L. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 1994, 24:1-9.
66. Norman W.H., Brown W.A., Miller I.W., Keitner G.I., Overholser J.C. The dexamethasone suppression test and completed suicide. Acta Psychiatr Scand 1990, 81:120-125.
67. Pandey G.N. Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies. Ann NY Acad Sci 1997, 836:182-200.
68. Pandey G.N., Dwivedi Y., Rizavi H.S., Ren X., Pandey S.C., Pesold C., Roberts R.C., Conley R.R., Tamminga C.A. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 2002, 159:419-429.
69. Pandey G.N., Ren X., Rizavi H.S., Conley R.R., Roberts R.C., Dwivedi Y. Brain derived neurotrophic factor and tyrosine kinase B receptor signalling in postmortem brain of teenage suicide victims. Int J Neuropsychopharmacol 2008, 11:1047-1061.
70. Papassotiropoulos A., Hawellek B., Frahnert C., Rao G.S., Rao M. The risk of acute suicidality in psychiatric inpatients increases with low plasma cholesterol. Pharmacopsychiatry 1999, 32:1-4.
71. Pfrieger F.W. Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci 2003, 60:1158-1171.
72. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973, 60:646-649.
73. Purselle D.C., Nemeroff C.B. Serotonin transporter: a potential substrate in the biology of suicide. Neuropsychopharmacology 2003, 28:613-619.
74. Quattrone A., Tedeschi G., Aguglia U., Scopacasa F., Direnzo G.F., Annunziato L. Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine. Br J Clin Pharmacol 1983, 16:471-475.
75. Reddy P.L., Khanna S., Subhash M.N., Channabasavanna S.M., Rao B.S. CSF amine metabolites in depression. Biol Psychiatry 1992, 31:112-118.
76. Ringo D.L., Lindley S.E., Faull K.F., Faustman W.O. Cholesterol and serotonin: seeking a possible link between blood cholesterol and CSF 5-HIAA. Biol Psychiatry 1994, 35:957-959.
77. Rogers J., Martin L.J., Comuzzie A.G., Mann J.J., Manuck S.B., Leland M., Kaplan J.R. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid. Biol Psychiatry 2004, 55:739-744.
78. Roy A. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression. Biol Psychiatry 1992, 32:812-816.
79. Samuelsson M., Jokinen J., Nordström A.L., Nordström P. CSF 5-HIAA, suicide intent and hopelessness in the prediction of early suicide in male high-risk suicide attempters. Acta Psychiatr Scand 2006, 113:44-47.
80. Sher L., Carballo J.J., Grunebaum M.F., Burke A.K., Zalsman G., Huang Y.Y., Mann J.J., Oquendo M.A. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Bipolar Disord 2006, 8:543-550.
81. Sher L., Oquendo M.A., Grunebaum M.F., Burke A.K., Huang Y.Y., Mann J.J. CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence. Eur Neuropsychopharmacol 2007, 17:12-15.
82. Singareddy R.K., Balon R. Sleep and suicide in psychiatric patients. Ann Clin Psychiatry 2001, 13:93-101.
83. Soloff P.H., Kelly T.M., Strotmeyer S.J., Malone K.M., Mann J.J. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder. Psychiatry Res 2003, 119:11-24.
84. Stockmeier C.A., Dilley G.E., Shapiro L.A., Overholser J.C., Thompson P.A., Meltzer H.Y. Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology 1997, 16:162-173.
85. Träskman-Bendz L., Alling C., Oreland L., Regnéll G., Vinge E., Ohman R. Prediction of suicidal behavior from biologic tests. J Clin Psychopharmacol 1992, 12:21S-26S.
86. Träskman-Bendz L., Ekman R., Regnéll G., Öhmann R. HPA-related CSF neuropeptides in suicide attempters. Eur Neuropsychopharmacol 1992, 2:99-106.
87. Underwood M.D., Khaibulina A.A., Ellis S.P., Moran A., Rice P.M., Mann J.J., Arango V. Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Biol Psychiatry 1999, 46:473-483.
88. Van Heeringen C., Marusic A. Understanding the suicidal brain. Br J Psychiatry 2003, 183:282-284.
89. Wallner B., Machatschke I.H. The evolution of violence in men: the function of central cholesterol and serotonin. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:391-397.
90. Yerevanian B.I., Feusner J.D., Koek R.J., Mintz J. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. J Affect Disord 2004, 83:103-108.